Paraneoplastic dermatomyositis with Kaposi’s sarcoma: A case report [PDF]
SAGE Open Medical Case ReportsDermatomyositis is a rare autoimmune condition known to be frequently associated with an undiagnosed malignancy. Although it is strongly linked to adenocarcinomas and other solid tumors, dermatomyositis has been scarcely described with sarcomas.
Shu Yu Qian +2 more
doaj +2 more sources
Trigeminal involvement in dermatomyositis with double positivity for anti-transcriptional intermediary factor 1 gamma and anti-Ku antibodies: A case report and literature review [PDF]
Journal of International Medical ResearchAnti-transcriptional intermediary factor 1 gamma antibody and anti-Ku antibody double-positive dermatomyositis and trigeminal neuropathy involvement are often regarded as clinically distinct diseases with differing pathogenesis. Herein, we present a rare
Sun Yingchao +5 more
doaj +2 more sources
Pneumomediastinum and Pneumopericardium in Rapidly Progressive Interstitial Lung Disease Secondary to Anti‐MDA5 Dermatomyositis [PDF]
Clinical Case ReportsAnti‐melanoma differentiation associated protein 5 antibody positive dermatomyositis (anti‐MDA5 dermatomyositis) is characterized by rapidly progressive interstitial lung disease and skin involvement with a paucity of muscle involvement.
Thomas Bond +3 more
doaj +2 more sources
Research progress on risk factors for dermatomyositis with malignancy
Pifu-xingbing zhenliaoxue zazhi, 2023 Malignant tumors are one of the major causes of mortality in patients with dermatomyositis. But the majority of these tumors are diagnosed after the diagnosis of dermatomyositis. Because the timing of diagnosis of tumor is associated with the survival of
Juanjuan PAN, Jing WANG, Guozhen TAN
doaj +1 more source
Paraneoplastic Wong-Type Dermatomyositis Associated with Gynecological Malignancy
Medicina, 2022 Although dermatomyositis is known to be a possible paraneoplastic syndrome, often in the setting of gynecological cancers, Wong-type dermatomyositis—a rare variant of dermatomyositis—has not been clearly associated with internal malignancies to date ...
Roberto Russo +4 more
doaj +1 more source
JTO Clinical and Research Reports, 2021 SCLC is frequently associated with paraneoplastic syndromes, including dermatomyositis. Patients with malignancy-associated dermatomyositis express a specific autoantibody pattern usually positive for anti–transcription intermediary factor 1-γ (TIF1-γ ...
Johnathan Arnon, MD +4 more
doaj +1 more source
, 2008 Dermatomyositis (DM) is a chronic inflammatory disorder of the skin and muscles. Although thought to be autoimmune in origin, many questions remain as to the etiopathogenesis of this disease. DM has classically been considered a humorally mediated disease.
M S, Krathen, D, Fiorentino, V P, Werth
openaire +4 more sources
Respiratory Medicine Case Reports, 2021 Tracheobronchial lesions are rare extramuscular complications for idiopathic inflammatory myopathies including dermatomyositis. We herein report a 65-year-old woman with tracheal ulcer during the progression of dermatomyositis-associated interstitial ...
Shintaro Sato +9 more
doaj +1 more source
Development and validation of a nomogram risk prediction model for malignancy in dermatomyositis patients: a retrospective study [PDF]
PeerJ, 2021 Background Dermatomyositis accompanied with malignancy is a common poor prognostic factor of dermatomyositis. Thus, the early prediction of the risk of malignancy in patients with dermatomyositis can significantly improve the prognosis of patients ...
Jiaojiao Zhong +5 more
doaj +2 more sources
Prevalence and reactivity of anti-melanoma differentiation-associated gene 5 (anti-MDA-5) autoantibody in Brazilian patients with dermatomyositis [PDF]
Anais Brasileiros de Dermatologia, 2018 : Background: There have been no studies to date on the frequency and reactivity of aanti-melanoma differentiation-associated gene 5 (anti-MDA-5) in samples from the Brazilian population with dermatomyositis. Objectives: To analyze this autoantibody in
Isabela Bruna Pires Borges +2 more
doaj +1 more source